92 related articles for article (PubMed ID: 15492837)
1. p16INK4a polymorphism: associations with tumour progression in patients with sporadic colorectal cancer.
McCloud JM; Sivakumar R; Greenhough A; Elder J; Jones PW; Deakin M; Elder JB; Fryer AA; Hoban PR
Int J Oncol; 2004 Nov; 25(5):1447-52. PubMed ID: 15492837
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the glutathione S-transferase mu cluster are associated with tumour progression and patient outcome in colorectal cancer.
Holley SL; Rajagopal R; Hoban PR; Deakin M; Fawole AS; Elder JB; Elder J; Smith V; Strange RC; Fryer AA
Int J Oncol; 2006 Jan; 28(1):231-6. PubMed ID: 16328000
[TBL] [Abstract][Full Text] [Related]
3. Interleukin promoter polymorphisms and prognosis in colorectal cancer.
Wilkening S; Tavelin B; Canzian F; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P; Försti A
Carcinogenesis; 2008 Jun; 29(6):1202-6. PubMed ID: 18448485
[TBL] [Abstract][Full Text] [Related]
4. Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients.
Fernández-Contreras ME; Sánchez-Hernández JJ; González E; Herráez B; Domínguez I; Lozano M; García De Paredes ML; Muñoz A; Gamallo C
Int J Oncol; 2009 Jan; 34(1):219-29. PubMed ID: 19082493
[TBL] [Abstract][Full Text] [Related]
5. Glutathione S-transferase T1 polymorphisms are associated with outcome in colorectal cancer.
Rajagopal R; Deakin M; Fawole AS; Elder JB; Elder J; Smith V; Strange RC; Fryer AA
Carcinogenesis; 2005 Dec; 26(12):2157-63. PubMed ID: 16051638
[TBL] [Abstract][Full Text] [Related]
6. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP
Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981
[TBL] [Abstract][Full Text] [Related]
7. A functional polymorphism (-347 G-->GA) in the E-cadherin gene is associated with colorectal cancer.
Shin Y; Kim IJ; Kang HC; Park JH; Park HW; Jang SG; Lee MR; Jeong SY; Chang HJ; Ku JL; Park JG
Carcinogenesis; 2004 Nov; 25(11):2173-6. PubMed ID: 15231691
[TBL] [Abstract][Full Text] [Related]
8. Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine eotaxin-1 in colorectal cancer patients.
Wågsäter D; Löfgren S; Hugander A; Dienus O; Dimberg J
World J Surg Oncol; 2007 Jul; 5():84. PubMed ID: 17672898
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.
Försti A; Li X; Wagner K; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
Genes Chromosomes Cancer; 2010 Mar; 49(3):270-81. PubMed ID: 19998449
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E gene polymorphism and colorectal cancer: gender-specific modulation of risk and prognosis.
Watson MA; Gay L; Stebbings WS; Speakman CT; Bingham SA; Loktionov A
Clin Sci (Lond); 2003 May; 104(5):537-45. PubMed ID: 12529167
[TBL] [Abstract][Full Text] [Related]
11. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.
Dimberg J; Hugander A; Löfgren S; Wågsäter D
Int J Mol Med; 2007 Jan; 19(1):11-5. PubMed ID: 17143542
[TBL] [Abstract][Full Text] [Related]
13. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Le Neel T; Le Houérou C; Faroux R; Ollivry J; Lafraise B; Chupin LD; Sébille V; Bézieau S
BMC Cancer; 2008 Nov; 8():326. PubMed ID: 18992148
[TBL] [Abstract][Full Text] [Related]
14. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
[TBL] [Abstract][Full Text] [Related]
15. SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer.
Chang SC; Lin PC; Yang SH; Wang HS; Li AF; Lin JK
Ann Surg Oncol; 2009 Aug; 16(8):2323-30. PubMed ID: 19472013
[TBL] [Abstract][Full Text] [Related]
16. A C/T polymorphism in the urokinase-type plasminogen activator gene in colorectal cancer.
Przybylowska K; Smolarczyk K; Blasiak J; Kulig A; Romanowicz-Makowska H; Dziki A; Ulanska J; Pander B
J Exp Clin Cancer Res; 2001 Dec; 20(4):569-72. PubMed ID: 11876553
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 receptor antagonist gene polymorphism in human colorectal cancer.
Viet HT; Wågsäter D; Hugander A; Dimberg J
Oncol Rep; 2005 Oct; 14(4):915-8. PubMed ID: 16142351
[TBL] [Abstract][Full Text] [Related]
18. Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression.
Cacev T; Radosević S; Krizanac S; Kapitanović S
Carcinogenesis; 2008 Aug; 29(8):1572-80. PubMed ID: 18628251
[TBL] [Abstract][Full Text] [Related]
19. No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk.
Van Der Logt EM; Janssen CH; Van Hooijdonk Z; Roelofs HM; Wobbes T; Nagengast FM; Peters WH
Anticancer Res; 2005; 25(2B):1465-70. PubMed ID: 15865106
[TBL] [Abstract][Full Text] [Related]
20. Heterozygosity for interleukin-18 -607 A/C polymorphism is associated with risk for colorectal cancer.
Nikiteas N; Yannopoulos A; Chatzitheofylaktou A; Tsigris C
Anticancer Res; 2007; 27(6B):3849-53. PubMed ID: 18225542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]